Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of precision medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age-related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Using Anti-TNF Therapy and Synthetic Cannabinoids for Pain and Inflammation with Dr. Jim Woody 180 Life Sciences TRANSCRIPT

Download PDF

Nov 29, 2023

Dr. Jim Woody, CEO and Director of 180 Life Sciences, discusses the company's vision for safer pain and inflammation management. Their earlier work on anti-TNF therapy revolutionized the treatment of conditions such as rheumatoid arthritis. Now 180 Life Sciences focuses on additional indications of inflammation,...

Read More

Using Anti-TNF Therapy and Synthetic Cannabinoids for Pain and Inflammation with Dr. Jim Woody 180 Life Sciences

Nov 29, 2023

Dr. Jim Woody, CEO and Director of 180 Life Sciences, discusses the company's vision for safer pain and inflammation management. Their earlier work on anti-TNF therapy revolutionized the treatment of conditions such as rheumatoid arthritis. Now 180 Life Sciences focuses on additional indications of inflammation,...

Read More

Sustained Postoperative Pain Management Without Risk of Opioid Addiction with Anthony Mack Virpax Pharma TRANSCRIPT

Download PDF

Oct 18, 2023

Anthony Mack, CEO of Virpax Pharma, is developing non-addictive pain drugs focusing on repurposing existing molecules and improving the delivery platform to enhance bioavailability and sustained delivery. With an initial focus on postoperative pain management and preventing opioid tolerance, their product, Probudur, is...

Read More

Sustained Postoperative Pain Management Without Risk of Opioid Addiction with Anthony Mack Virpax Pharma

Oct 18, 2023

Anthony Mack, CEO of Virpax Pharma, is developing non-addictive pain drugs focusing on repurposing existing molecules and improving the delivery platform to enhance bioavailability and sustained delivery. With an initial focus on postoperative pain management and preventing opioid tolerance, their product, Probudur, is...

Read More

Targeting Voltage-Gated Sodium Channels to Treat Hypersensitivity to Pain with John Mulcahy SiteOne Therapeutics TRANSCRIPT

Download PDF

Jul 11, 2023

John Mulcahy, President and CEO of SiteOne Therapeutics, is developing new therapies to treat hypersensitivity disorders.  Their approach focuses on targeting specific voltage-gated sodium channels. Their drug candidates are designed to treat acute pain, as well as hypersensitivity developed as a result of chronic...

Read More